Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1987
11/11/1987EP0244834A2 Process for producing a factor V concentrate
11/11/1987EP0244627A2 Expression vectors for the production of polypeptides
11/11/1987CN87102725A 重组产品 Recombinant Products
11/11/1987CN87102497A Alpha interferon analogue
11/11/1987CN87100480A Method and composition for prophylaxis and treatment of viral infections
11/11/1987CN86108016A De-(acetylglucosaminyl)-di(dehydro)-deoxy teicoplanin derivatives
11/10/1987US4705846 Novel renin inhibiting peptides having a gamma lactam pseudo dipeptide insert
11/10/1987US4705778 Orally active LHRH analogs
11/10/1987US4705777 Cationic oligopeptides having microbicidal activity
11/10/1987US4705753 Biologically active acrylonitrile-based copolymeric membrane
11/10/1987US4705687 Treatment of autoimmune diseases such as rheumatoid arthritis with suppressor factor
11/10/1987US4705685 Methods and materials for treatment of disease states involving immunological factors
11/10/1987US4705682 Oligopeptide derivatives, their production and their use as surfactants gentle to the skin
11/09/1987EP0205555A4 Serine protease inhibitors and methods for isolation of same.
11/05/1987WO1987006617A2 Detection of a unique chlamydia strain associated with acute respiratory disease
11/05/1987WO1987006616A1 Monoclonal antibodies and their use
11/05/1987WO1987006613A1 RECOMBINANT PLASMID DNA pVN22, CODING FOR BIOSYNTHESIS OF HUMAN LEUCOCYTE INTERFERON alpha-I1 AND STRAIN PSEUDOMONAS sp. 31 (pVN22) - PRODUCER OF HUMAN LEUCOCYTE INTERFERON alpha-I1 CONTAINING IT
11/05/1987WO1987006591A1 Immunosuppressive factor
11/05/1987WO1987006590A1 Immunopotentiation
11/05/1987WO1987006588A1 Recombinant alveolar surfactant protein
11/05/1987WO1987006469A1 Monoclonal antibodies and their use
11/05/1987WO1987006468A1 Monoclonal antibodies and their use
11/05/1987WO1987006466A1 Method of regulating animal reproduction
11/05/1987WO1987006463A1 A composition having reduced nephrotoxicity comprising a fatty acid containing component and cyclosporine
11/05/1987WO1987006460A1 Dispersion of lipidic spherules
11/05/1987WO1987003883A3 Use of oligopeptides in the treatment of viral infections
11/05/1987DE3614904A1 Cyclic peptides with cytoprotective action
11/04/1987EP0244295A1 Immunogene isolated from molluscs, process for its preparation, diagnostic reactants for human bilharzioses, vaccines against schistosomiases and immune compositions containing this immunogene
11/04/1987EP0244267A2 Variants of decay accelerating factor (DAF) prepared by recombinant DNA technology
11/04/1987EP0244189A2 Human pancreatic elastase I
11/04/1987EP0244169A2 Peptides having ANF activity
11/04/1987EP0243929A2 Polypeptide and protein derivatives and process for their preparation
11/04/1987EP0243716A1 Encapsulation of ancrod for oral administration
11/04/1987EP0243645A2 Compounds having a nootropic activity, agents containing them and their use in the treatment and prophylaxis of cognitive malfunctions
11/04/1987EP0243477A1 Renin inhibitors and methods for using same
11/04/1987CN86108331A Radiohalogenated small molecules for protein labeling
11/03/1987US4704451 Thrombin segment
11/03/1987US4704450 Synthesis of hpGRF(Somatocrinin) in liquid phase and intermediate peptides
11/03/1987US4704273 Methods and materials for treatment of rheumatoid arthritis
11/03/1987CA1228874A1 Apparatus for introducing stacks of paper layers into cartons
11/03/1987CA1228864A1 Leukotriene antagonists intermediates
11/03/1987CA1228813A2 Antiallergic pharmaceutical compositions containing one or more glycoproteins from klebsiella pneumoniae
10/1987
10/29/1987DE3613848A1 Use of anti-idiotype antibodies
10/28/1987EP0243204A2 Infective drug delivery system
10/28/1987EP0243179A1 Wound healing composition
10/28/1987EP0243174A2 Monoclonal antibodies to Pseudomonas aeruginosa exoenzyme S, their preparation and use
10/28/1987EP0243058A2 A tumor associated antigen
10/28/1987EP0243029A1 Recombinant vaccinia virus expressing human retrovirus gene
10/28/1987EP0242836A1 Tissue plasminogen activator (tPA) derivative and its production
10/28/1987EP0242799A2 Cystein-enriched unities of gamma-glutamic acid and beta-alanine, process for their preparation and their use
10/28/1987EP0242752A2 Use of TNF for the preparation of medicaments
10/28/1987EP0242653A1 tPA-containing medical composition and use thereof
10/28/1987EP0242643A2 Nasal administration of drugs
10/28/1987EP0242466A1 Osteogenic use of partially purified bone-inducing factor
10/28/1987EP0242416A1 Method of protein stabilization
10/28/1987CN86108380A Monoclonal antibodies cross-reactive and crossprotective against p. aeruginosa serotypes
10/27/1987USRE32534 Peptides, process for preparing the same and psychodepressant compositions containing the same
10/27/1987US4703107 Water-soluble acylated derivatives of peptides or amino acids, their preparation and their use
10/27/1987US4703106 Novel polypeptide and process for producing the same
10/27/1987US4703054 Learning enhancement
10/27/1987US4703039 Complex of peptide and carrier
10/27/1987US4703038 Combination of dihydropyridines with angiotensin converting enzymes-inhibitors
10/27/1987US4703037 Hypotensive agents
10/27/1987US4703036 Anticoagulants
10/27/1987US4703035 Polypeptides
10/27/1987US4703033 Novel cyclosporins
10/27/1987US4703008 DNA sequences encoding erythropoietin
10/27/1987US4703004 Synthesis of protein with an identification peptide
10/27/1987US4702912 Bioactive compositions affecting human skin tissue
10/27/1987US4702910 Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for pretecting Pseudomonas aeruginosa infection
10/27/1987US4702908 Parenteral dosage form in carrier for mammals
10/27/1987US4702907 Process for inducing selective immunosuppression of antibodies
10/27/1987CA1228543A1 .alpha.-LACTALBUMIN CONTRACEPTIVE
10/27/1987CA1228542A1 Lyophilized compositions, preparations and use thereof
10/22/1987WO1987006263A1 Fibrin-specific antibodies and method of screening for the antibodies
10/22/1987WO1987006262A1 Recombinant vaccinia virus expressing human retrovirus gene
10/22/1987WO1987006260A1 Viral vector coding for a glycoprotein of the virus responsible for a.i.d.s., vaccine and antibody
10/22/1987WO1987006258A1 A cell line producing aids viral antigens without producing infectious virus particles
10/22/1987WO1987006240A1 Heterobifunctional antibodies and method of use
10/22/1987WO1987006239A1 Hepatoma-derived growth factor
10/22/1987WO1987006137A1 An insulin preparation for non-parenteral administration
10/22/1987WO1987006136A1 Increased vascular perfusion following administration of lipids
10/22/1987WO1987005300A3 Protein preservation
10/22/1987WO1987002673A3 Process for activating heterologous, eucaryotic proteins genetically engineered and presenting disulphide bridges after their expression in procaryotic cells
10/21/1987EP0242329A2 Monoclonal antibodies against interferon-induced human protein in pure form, and test kits containing these antibodies
10/21/1987EP0242233A2 Lymphokines for use in the treatment of infections
10/21/1987EP0242154A2 A novel tumor-associated antigen
10/21/1987EP0241926A2 Peptide, process for synthesizing it, pharmaceutical composition containing it and use
10/21/1987EP0241907A2 Heterobifunctional antibodies and method of use
10/21/1987EP0241889A2 Use of TNF for the preparation of medicaments
10/21/1987EP0241830A2 Hepatoma-derived growth factor
10/21/1987EP0241811A2 Monoclonal antibodies against the human interleukin-2 receptor
10/21/1987EP0241797A2 Novel spergualin-related compounds and process for producing the same
10/21/1987EP0241725A2 Improvements in and relating to vaccines
10/21/1987EP0241539A1 Expression systems for overproduction of desired proteins.
10/21/1987EP0241533A1 Rapid acting intravenous emulsions of omega-3 fatty acid esters.
10/21/1987EP0241487A1 Method and means for sorting and identifying biological information
10/20/1987US4701442 Treatment of symptoms of neoplastic diseases with nucleoproteins
10/20/1987US4701441 Methods and compositions for stimulation of appetite
10/20/1987US4701440 Sustained release